相似文献
1
A new day for human challenge trials?
Trends Mol Med. 2022 Jul;28(7):531-532. doi: 10.1016/j.molmed.2022.05.002. Epub 2022 May 22.
2
The Ethics of Human Challenge Trials Using Emerging Severe Acute Respiratory Syndrome 2 Variants.
J Infect Dis. 2022 Mar 15;225(6):934-937. doi: 10.1093/infdis/jiab488.
3
An ongoing science-society-ethics experiment: The human challenge trial debate in COVID-19 pandemic: The human challenge trial debate in COVID-19 pandemic.
EMBO Rep. 2022 Jan 5;23(1):e54184. doi: 10.15252/embr.202154184. Epub 2021 Dec 13.
4
Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines.
J Med Ethics. 2020 Dec;46(12):808-812. doi: 10.1136/medethics-2020-106501. Epub 2020 Jul 13.
5
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
6
Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events.
Ethics Hum Res. 2020 Jul;42(4):24-34. doi: 10.1002/eahr.500056. Epub 2020 May 22.
7
Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure.
Clin Microbiol Infect. 2021 Mar;27(3):372-377. doi: 10.1016/j.cmi.2020.12.032. Epub 2021 Jan 6.
8
The Case for Human Challenge Trials in COVID-19.
J Bioeth Inq. 2024 Mar;21(1):151-165. doi: 10.1007/s11673-023-10309-9. Epub 2023 Sep 18.
9
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
10
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
本文引用的文献
1
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.
Nat Med. 2022 May;28(5):1031-1041. doi: 10.1038/s41591-022-01780-9. Epub 2022 Mar 31.
2
Universal Coronavirus Vaccines - An Urgent Need.
N Engl J Med. 2022 Jan 27;386(4):297-299. doi: 10.1056/NEJMp2118468. Epub 2021 Dec 15.
3
COVID-19: release approved vaccines for trials of new ones.
Nature. 2021 Sep;597(7875):178. doi: 10.1038/d41586-021-02398-6.
4
Do coronavirus vaccine challenge trials have a distinctive generalisability problem?
J Med Ethics. 2022 Sep;48(9):586-589. doi: 10.1136/medethics-2020-107109. Epub 2021 Jun 7.
5
Exploring Risks of Human Challenge Trials For COVID-19.
Risk Anal. 2021 May;41(5):710-720. doi: 10.1111/risa.13726. Epub 2021 May 4.
6
Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure.
Clin Microbiol Infect. 2021 Mar;27(3):372-377. doi: 10.1016/j.cmi.2020.12.032. Epub 2021 Jan 6.
7
Back to WHAT? The role of research ethics in pandemic times.
Med Health Care Philos. 2021 Mar;24(1):3-20. doi: 10.1007/s11019-020-09984-x. Epub 2020 Nov 3.
8
Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models.
N Engl J Med. 2020 Sep 3;383(10):e63. doi: 10.1056/NEJMp2020076. Epub 2020 Jul 1.
9
The ethical challenge of infection-inducing challenge experiments.
Clin Infect Dis. 2001 Oct 1;33(7):1028-33. doi: 10.1086/322664. Epub 2001 Sep 5.
Zotero 插件